Abdullah Hacıhanefioğlu

649 total citations
30 papers, 424 citations indexed

About

Abdullah Hacıhanefioğlu is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Abdullah Hacıhanefioğlu has authored 30 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 9 papers in Oncology and 8 papers in Genetics. Recurrent topics in Abdullah Hacıhanefioğlu's work include Chronic Lymphocytic Leukemia Research (4 papers), Multiple Myeloma Research and Treatments (4 papers) and Blood disorders and treatments (4 papers). Abdullah Hacıhanefioğlu is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Multiple Myeloma Research and Treatments (4 papers) and Blood disorders and treatments (4 papers). Abdullah Hacıhanefioğlu collaborates with scholars based in Türkiye, United States and Antigua and Barbuda. Abdullah Hacıhanefioğlu's co-authors include Pınar Tarkun, Emel Gönüllü, Özgür Mehtap, Reyhan Diz Küçükkaya, Hüseyin Levent Keskin, Mustafa Nuri Yenerel, Mehmet Turgut, Meliha Nalçacı, Ömer Şentürk and Altay Çelebi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Diabetes Research and Clinical Practice.

In The Last Decade

Abdullah Hacıhanefioğlu

28 papers receiving 412 citations

Peers

Countries citing papers authored by Abdullah Hacıhanefioğlu

Since Specialization

Citations

This map shows the geographic impact of Abdullah Hacıhanefioğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdullah Hacıhanefioğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdullah Hacıhanefioğlu more than expected).

Fields of papers citing papers by Abdullah Hacıhanefioğlu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdullah Hacıhanefioğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdullah Hacıhanefioğlu. The network helps show where Abdullah Hacıhanefioğlu may publish in the future.

Co-authorship network of co-authors of Abdullah Hacıhanefioğlu

This figure shows the co-authorship network connecting the top 25 collaborators of Abdullah Hacıhanefioğlu. A scholar is included among the top collaborators of Abdullah Hacıhanefioğlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdullah Hacıhanefioğlu. Abdullah Hacıhanefioğlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effects of AGEs, sRAGE and HMGB1 on Clinical Outcomes in Multiple Myeloma 2022 ·Indian Journal of Hematology and Blood Transfusion ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Özgür Mehtap, Pınar Tarkun, Abdullah Hacıhanefioğlu	4
2	Programmed Cell Death Ligand 1 Expression Level and Prognostic Significance in Acute Myeloid Leukemia 2021 ·Indian Journal of Hematology and Blood Transfusion ·(unknown), (unknown), Özgür Mehtap, (unknown), (unknown), Pınar Tarkun, Abdullah Hacıhanefioğlu, (unknown)	1
3	The Role of Interim PET/CT on Survival in Diffuse Large B Cell Lymphoma 2021 ·Clinical Lymphoma Myeloma & Leukemia ·(unknown), Özgür Mehtap, (unknown), (unknown), (unknown), (unknown), Pınar Tarkun, Abdullah Hacıhanefioğlu	2
4	Prognostic Value of Serum Soluble Klotho and Fibroblast Growth Factor-23 in Multiple Myeloma Patients 2021 ·Indian Journal of Hematology and Blood Transfusion ·(unknown), Özgür Mehtap, (unknown), Pınar Tarkun, (unknown), Necmi Eren, Abdullah Hacıhanefioğlu	0
5	Dasatinib-induced immune mediated-thrombotic thrombocytopenic purpura 2018 ·Transfusion and Apheresis Science ·(unknown), Özgür Mehtap, (unknown), Pınar Tarkun, Necmi Eren, (unknown), Abdullah Hacıhanefioğlu	10
6	Carfilzomib-induced tumor lysis syndrome in relapsed multiple myeloma: a report of two cases 2018 ·Tumori Journal ·(unknown), (unknown), Necmi Eren, (unknown), Özgür Mehtap, Pınar Tarkun, Abdullah Hacıhanefioğlu	4
7	Eficacia de piperacilina-tazobactam y cefoperazona-sulbactam en el tratamiento de pacientes con neutropenia febril 2016 ·Revista española de quimioterapia. Suplemento ·(unknown), Birsen Mutlu, Abdullah Hacıhanefioğlu	6
8	Serum Angiopoietin Levels are Different in Acute and Chronic Myeloid Neoplasms: Angiopoietins do not only Regulate Tumor Angiogenesis 2015 ·Indian Journal of Hematology and Blood Transfusion ·(unknown), Pınar Tarkun, Özgür Mehtap, (unknown), (unknown), (unknown), (unknown), Abdullah Hacıhanefioğlu	7
9	Isolated Breast Relapse of Acute Lymphoblastic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation 2015 ·Indian Journal of Hematology and Blood Transfusion ·(unknown), (unknown), Pınar Tarkun, (unknown), (unknown), Abdullah Hacıhanefioğlu, (unknown)	3
10	The Role of β-Catenin in Bcr/Abl Negative Myeloproliferative Neoplasms: An Immunohistochemical Study 2015 ·Clinical Lymphoma Myeloma & Leukemia ·(unknown), (unknown), Pınar Tarkun, Özgür Mehtap, Abdullah Hacıhanefioğlu, (unknown), Canan Baydemır	11
11	Beta-2 microglobulin predicts the outcome after autologous stem cell transplantation in non-Hodgkin lymphoma 2014 ·Transfusion and Apheresis Science ·(unknown), Abdullah Hacıhanefioğlu, Zafer Gülbaş	2
12	Decreased serum heat shock protein 60 levels in newly diagnosed immune thrombocytopenia patients 2014 ·Platelets ·(unknown), (unknown), Pınar Tarkun, Özgür Mehtap, (unknown), Atalay Doğru, Abdullah Hacıhanefioğlu	2
13	IL-21 and other serum proinflammatory cytokine levels in patients with multiple myeloma at diagnosis 2014 ·Journal of Postgraduate Medicine ·Özgür Mehtap, (unknown), Pınar Tarkun, Abdullah Hacıhanefioğlu, (unknown), (unknown)	17
14	Association of Gene Polymorphisms and Leukocytosis with Thrombotic Complications in Essential Thrombocytemia and Polycythemia Vera 2012 ·SHILAP Revista de lepidopterología ·Özgür Mehtap, (unknown), Pınar Tarkun, Emel Gönüllü, (unknown), (unknown), (unknown), (unknown), Abdullah Hacıhanefioğlu	7
15	Are cup-like blasts specific to AML patients with FLT3 ITD and a normal karyotype? An ALL case report and review of the literature 2011 ·SHILAP Revista de lepidopterología ·Özgür Mehtap, (unknown), Emel Gönüllü, (unknown), Abdullah Hacıhanefioğlu	2
16	Effect of heat shock protein-90 (HSP90) and vascular endothelial growth factor (VEGF) on survival in acute lymphoblastic leukemia: an immunohistochemical study 2010 ·Medical Oncology ·Abdullah Hacıhanefioğlu, Emel Gönüllü, Özgür Mehtap, (unknown), (unknown), Cengiz Erçín	10
17	Acute severe cardiac failure in a myeloma patient due to proteasome inhibitor bortezomib 2008 ·International Journal of Hematology ·Abdullah Hacıhanefioğlu, Pınar Tarkun, Emel Gönüllü	83
18	Multiple littoral cell angioma of the spleen in a case of myelodysplastic syndrome 2005 ·Hematology ·Cengiz Erçín, Yeşim Gürbüz, Abdullah Hacıhanefioğlu, (unknown)	11
19	Anticardiolipin and anti-β2 glycoprotein I antibody concentrations in patients with type 2 diabetes mellitus 2004 ·Diabetes Research and Clinical Practice ·İlhan Tarkun, Abdullah Hacıhanefioğlu, Pınar Tarkun, Berrin Çetinarslan, Zeynep Cantürk	6
20	Hepatic and splenic uptake of Tc-99m HDP in multiple myeloma: Additional findings on Tc-99m MIBI and Tc-99m sulfur colloid images 2002 ·Annals of Nuclear Medicine ·Fatma Berk, Hakan Demir, Abdullah Hacıhanefioğlu, Arzu Arslan, (unknown), (unknown), Cumali Aktolun	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact